文献速递脑血管病神经重症与神经感染

移动卒中单元管理对适合静脉溶栓的急性缺血性卒中患者的效果

Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis.
PubMed 文献 · JAMA Neurol · 2024-01-01

这项回顾性观察性队列研究基于美国心脏协会GWTG-Stroke注册数据,纳入2018年8月1日至2023年1月31日106家医院的19433例缺血性卒中患者,其中1237例(6.4%)接受移动卒中单元院前管理。移动卒中单元管理相比标准急救医疗服务管理与出院时更好的效用加权改良Rankin量表评分相关(校正均差0.03,95%CI 0.01-0.05),且独立行走可能性更高(53.3% vs 48.3%;aRR 1.08,95%CI 1.03-1.13),症状性颅内出血和院内死亡率无统计学显著差异。

要点

  • 移动卒中单元管理组出院时效用加权改良Rankin量表评分优于标准急救医疗服务管理组(校正均差0.03,95%CI 0.01-0.05)。
  • 移动卒中单元管理组出院时独立行走比例53.3%,标准急救医疗服务管理组48.3%(aRR 1.08,95%CI 1.03-1.13)。
  • 两组症状性颅内出血(aRR 1.30,95%CI 0.94-1.75)和院内死亡率(aRR 1.03,95%CI 0.78-1.27)无统计学显著差异。

核心结论

  • 在可能适合静脉溶栓的急性缺血性卒中患者中,移动卒中单元院前管理相比标准急救医疗服务管理与出院时显著更低的整体残疾水平相关。
  • 这些发现支持扩大移动卒中单元院前管理可及性的政策努力。

研究设计与样本

  • 回顾性观察性队列研究,纳入2018年8月1日至2023年1月31日期间最终诊断为缺血性卒中且接受移动卒中单元院前管理或标准急救医疗服务管理的连续患者,随访至出院。
  • 主要分析队列为可能适合静脉溶栓的患者;另分析了一个包含所有患者(无论诊断)的重叠队列。
  • 患者数据来自美国心脏协会Get With The Guidelines-Stroke(GWTG-Stroke)项目,这是一个全国性多中心质量保证注册系统;分析于2024年5月完成。
  • 共纳入106家医院的19433例患者(中位[IQR]年龄73[62-83]岁;女性9867例[50.8%]),其中1237例(6.4%)接受移动卒中单元院前管理。

主要发现

  • 移动卒中单元院前管理与出院时更好的效用加权改良Rankin量表评分相关(校正均差0.03;95%CI 0.01-0.05)。
  • 移动卒中单元院前管理与出院时更高的独立行走可能性相关(53.3%[468/878] vs 48.3%[5868/12148];校正风险比1.08;95%CI 1.03-1.13)。
  • 两组症状性颅内出血无统计学显著差异(5.2%[57/1094] vs 4.2%[545/13014];校正风险比1.30;95%CI 0.94-1.75)。
  • 两组院内死亡率无统计学显著差异(5.7%[70/1237] vs 6.2%[1121/18196];校正风险比1.03;95%CI 0.78-1.27)。

关键数值与推荐

  • 主要疗效终点为效用加权改良Rankin量表评分,移动卒中单元组校正均差0.03(95%CI 0.01-0.05)。
  • 次要疗效终点为独立行走状态,移动卒中单元组53.3%(468/878)vs 标准急救医疗服务组48.3%(5868/12148),校正风险比1.08(95%CI 1.03-1.13)。
  • 共同主要安全终点为症状性颅内出血(移动卒中单元组5.2%[57/1094] vs 标准急救医疗服务组4.2%[545/13014];校正风险比1.30,95%CI 0.94-1.75)和院内死亡率(移动卒中单元组5.7%[70/1237] vs 标准急救医疗服务组6.2%[1121/18196];校正风险比1.03,95%CI 0.78-1.27)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Clinical trials have suggested that prehospital management in a mobile stroke unit (MSU) improves functional outcomes in patients with acute ischemic stroke who are potentially eligible for intravenous thrombolysis, but there is a paucity of real-world evidence from routine clinical practice on this topic. OBJECTIVE: To determine the association between prehospital management in an MSU vs standard emergency medical services (EMS) management and the level of global disability at hospital discharge. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective, observational, cohort study that included consecutive patients with a final diagnosis of ischemic stroke who received either prehospital management in an MSU or standard EMS management between August 1, 2018, and January 31, 2023. Follow-up ended at hospital discharge. The primary analytic cohort included those who were potentially eligible for IV thrombolysis. A separate, overlapping cohort including all patients regardless of diagnosis was also analyzed. Patient data were obtained from the American Heart Association's Get With The Guidelines-Stroke (GWTG-Stroke) Program, a nationwide, multicenter quality assurance registry. This analysis was completed in May 2024. EXPOSURE: Prehospital management in an MSU (vs standard EMS management). MAIN OUTCOMES AND MEASURES: The primary efficacy end point was the utility-weighted modified Rankin Scale (UW-mRS) score. The secondary efficacy end point was independent ambulation status. The coprimary safety end points were symptomatic intracranial hemorrhage (sICH) and in-hospital mortality. RESULTS: Of 19 433 patients (median [IQR] age, 73 [62-83] years; 9867 female [50.8%]) treated at 106 hospitals, 1237 (6.4%) received prehospital management in an MSU. Prehospital management in an MSU was associated with a better score on the UW-mRS at discharge (adjusted mean difference, 0.03; 95% CI, 0.01-0.05) and a higher likelihood of independent ambulation at discharge (53.3% [468 of 878 patients] vs 48.3% [5868 of 12 148 patients]; adjusted risk ratio [aRR], 1.08; 95% CI, 1.03-1.13). There was no statistically significant difference in sICH (5.2% [57 of 1094] vs 4.2% [545 of 13 014]; aRR, 1.30; 95% CI, 0.94-1.75]) or in-hospital mortality (5.7% [70 of 1237] vs 6.2% [1121 of 18 196]; aRR, 1.03; 95% CI, 0.78-1.27) between the 2 groups. CONCLUSIONS AND RELEVANCE: Among patients with acute ischemic stroke potentially eligible for intravenous thrombolysis, prehospital management in an MSU compared with standard EMS management was associated with a significantly lower level of global disability at hospital discharge. These findings support policy efforts to expand access to prehospital MSU management.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Mac Grory B, Sun JL, Alhanti B, et al. Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis. JAMA Neurol. 2024. PMID: 39466286. doi:10.1001/jamaneurol.2024.3659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。